| 臺大學術典藏 |
2021-02-02T02:21:10Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:02Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU; Yang T.-H.; Kao J.-H.; Chen C.-C.; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:00Z |
Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy
|
Chien N.-H.; Huang Y.-T.; Wu C.-Y.; Chang C.-Y.; MING-SHIANG WU; Kao J.-H.; Mo L.-R.; Tai C.-M.; Lin C.-W.; Yang T.-H.; Lin J.-T.; Hsu Y.-C. |
| 臺大學術典藏 |
2021-02-02T02:20:49Z |
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
|
Hsu Y.-C.; Nguyen M.H.; Mo L.-R.; MING-SHIANG WU; Yang T.-H.; Chen C.-C.; Tseng C.-H.; Tai C.-M.; Wu C.-Y.; Lin J.-T.; Tanaka Y.; Chang C.-Y. |
| 臺大學術典藏 |
2021-01-15T03:52:53Z |
Chronic calcifying pancreatitis in Taiwan: A multicentric study and comparison with western countries
|
Lin C.-C.; HSIU-PO WANG; Chen M.-F.; Soon M.-S.; Mo L.-R.; Lin X.-Z.; Lin S.-H.; Yang T.-H.; Wang T.-H.; Lin J.-T. |
| 臺大學術典藏 |
2021-01-15T03:46:50Z |
Effectiveness of intragastric balloon treatment for obese patients: One-year follow-up after balloon removal
|
Tai C.-M.; Lin H.-Y.; Yen Y.-C.; Huang C.-K.; Hsu W.-L.; Huang Y.-W.; Chang C.-Y.; HSIU-PO WANG; Mo L.-R. |
| 臺大學術典藏 |
2021-01-15T03:46:44Z |
Circumferential balloon-based radiofrequency ablation for ultralong and extensive flat esophageal squamous neoplasia
|
Wang W.-L.; Chang I.-W.; Chang C.-Y.; Lin J.-T.; Mo L.-R.; HSIU-PO WANG; Lee C.-T. |
| 臺大學術典藏 |
2021-01-15T03:46:43Z |
Radiofrequency ablation versus endoscopic submucosal dissection in treating large early esophageal squamous cell Neoplasia
|
Wang W.-L.; Chang I.-W.; Chen C.-C.; Chang C.-Y.; Mo L.-R.; Lin J.-T.; HSIU-PO WANG; Lee C.-T. |
| 臺大學術典藏 |
2021-01-15T03:46:38Z |
The Spatial Predilection for Early Esophageal Squamous Cell Neoplasia
|
Wang W.-L.; Chang I.-W.; Chen C.-C.; Chang C.-Y.; Lin J.-T.; Mo L.-R.; HSIU-PO WANG; Lee C.-T. |
| 臺大學術典藏 |
2021-01-15T03:46:35Z |
A case series on the use of circumferential radiofrequency ablation for early esophageal squamous neoplasias in patients with esophageal varices
|
Wang W.-L.; Chang I.-W.; Chen C.-C.; Chang C.-Y.; Mo L.-R.; Lin J.-T.; HSIU-PO WANG; Lee C.-T. |
| 臺大學術典藏 |
2021-01-15T03:46:35Z |
Role of computed tomography angiography on the management of overt obscure gastrointestinal bleeding
|
Tseng C.-M.; Lin I.-C.; Chang C.-Y.; HSIU-PO WANG; Chen C.-C.; Mo L.-R.; Lin J.-T.; Tai C.-M. |
| 臺大學術典藏 |
2021-01-15T03:46:32Z |
Biliopancreatic endoscopy: Practical application
|
Lai K.-H.; Mo L.-R.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-04T07:32:20Z |
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
|
You S.-L.; MEI-HWEI CHANG; Chen C.-J.; Liu C.-J.; Lai M.-W.; Wu T.-C.; Wu S.-F.; Lee C.-M.; Yang S.-S.; Chu H.-C.; Wang T.-E.; Chen B.-W.; Chuang W.-L.; Soon M.-S.; Lin C.-Y.; Chiou S.-T.; Kuo H.-S.; Chen D.-S.; Yang Y.-J.; Lo G.-H.; Kong M.-S.; Wang P.-M.; Yang C.-C.; Chu C.-H.; Lin L.-H.; Chien R.-N.; Lee T.-H.; Yang K.-C.; Liao L.-Y.; Mo L.-R.; Liu J.-D.; Yang T.-H.; Lo C.-C.; Tsai M.-H.; Chou C.-H.; Cheng Y.-S. |
| 國立成功大學 |
2021 |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang, C.-F.;Kuo, H.-T.;Chang, T.-S.;Lo, C.-C.;Hung, C.-H.;Huang, C.-W.;Chong, L.-W.;Cheng, P.-N.;Yeh, M.-L.;Peng, C.-Y.;Cheng, Cheng C.-Y.;Huang, J.-F.;Bair, M.-J.;Lin, C.-L.;Yang, C.-C.;Wang, S.-J.;Hsieh, T.-Y.;Lee, T.-H.;Lee, P.-L.;Wu, Wu W.-C.;Lin, C.-L.;Su, W.-W.;Yang, S.-S.;Wang, C.-C.;Hu, J.-T.;Mo, L.-R.;Chen, Chen C.-T.;Huang, Y.-H.;Chang, Chang C.-C.;Huang, C.-S.;Chen, G.-Y.;Kao, C.-N.;Tai, C.-M.;Liu, C.-J.;Lee, M.-H.;Tsai, P.-C.;Dai, C.-Y.;Kao, J.-H.;Lin, H.-C.;Chuang, W.-L.;Chen, Chen C.-Y.;Tseng, K.-C.;Yu, M.-L. |
| 國立成功大學 |
2021 |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
|
Chen, Chen C.-Y.;Huang, C.-F.;Cheng, P.-N.;Tseng, K.-C.;Lo, C.-C.;Kuo, H.-T.;Huang, Y.-H.;Tai, C.-M.;Peng, C.-Y.;Bair, M.-J.;Chen, Chen C.-H.;Yeh, M.-L.;Lin, C.-L.;Lin, C.-Y.;Lee, P.-L.;Chong, L.-W.;Hung, C.-H.;Huang, J.-F.;Yang, C.-C.;Hu, J.-T.;Lin, C.-W.;Chen, Chen C.-T.;Wang, C.-C.;Su, W.-W.;Hsieh, T.-Y.;Lin, C.-L.;Tsai, W.-L.;Lee, T.-H.;Chen, G.-Y.;Wang, S.-J.;Chang, Chang C.-C.;Mo, L.-R.;Yang, S.-S.;Wu, Wu W.-C.;Huang, C.-S.;Hsiung, C.-K.;Kao, C.-N.;Tsai, P.-C.;Liu, C.-H.;Lee, M.-H.;Liu, C.-J.;Dai, C.-Y.;Kao, J.-H.;Chuang, W.-L.;Lin, H.-C.;Yu, M.-L. |
| 臺大學術典藏 |
2020-11-27T03:28:38Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-27T03:28:37Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Yang T.-H.; Kao J.-H.; CHIEH-CHANG CHEN; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-27T03:28:35Z |
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
|
Hsu Y.-C.; Nguyen M.H.; Mo L.-R.; Wu M.-S.; Yang T.-H.; CHIEH-CHANG CHEN; Tseng C.-H.; Tai C.-M.; Wu C.-Y.; Lin J.-T.; Tanaka Y.; Chang C.-Y. |
| 臺大學術典藏 |
2020-11-19T03:19:31Z |
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
|
Lin C.-W.; Lin C.-C.; Mo L.-R.; Chang C.-Y.; Perng D.-S.; Hsu C.-C.; Lo G.-H.; Chen Y.-S.; Yen Y.-C.; Hu J.-T.; Yu M.-L.; PO-HUANG LEE; Lin J.-T.; Yang S.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen�VNegative Patients
|
Lin J.-T.; Wu C.-Y.; Hung H.-W.; Fang Y.-J.; Chen C.-C.; Chiang M.-F.; Wang C.-S.; Yang T.-H.; Wang W.-L.; Kao J.-H.; MING-SHIANG WU; Chang C.-Y.; Hsu Y.-C.; Mo L.-R. |
| 臺大學術典藏 |
2020-11-02T02:04:21Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Lin J.-T.; Wu C.-Y.; Lin C.-W.; Tai C.-M.; Chen C.-C.; Tseng C.-H.; Kao J.-H.; Yang T.-H.; MING-SHIANG WU; Chang C.-Y.; Mo L.-R.; Hsu Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:10Z |
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
|
Chang C.-Y.; Lin J.-T.; Tanaka Y.; Wu C.-Y.; Tseng C.-H.; Tai C.-M.; Hsu Y.-C.; Nguyen M.H.; Mo L.-R.; MING-SHIANG WU; Yang T.-H.; Chen C.-C. |
| 臺大學術典藏 |
2020-08-11T08:36:45Z |
Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy
|
PO-CHIN LIANG; Chen Y.-C.; Chiang C.-F.; Mo L.-R.; Wei S.-Y.; Hsieh W.-Y.; Lin W.-L. |
| 臺大學術典藏 |
2020-02-26T09:00:49Z |
Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy
|
Liang P.-C.; Chen Y.-C.; Chiang C.-F.; Mo L.-R.; Wei S.-Y.; Hsieh W.-Y.; Win-Li Lin |
| 臺大學術典藏 |
2018-09-10T18:03:52Z |
Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy
|
Chien, N.-H.;Huang, Y.-T.;Wu, C.-Y.;Chang, C.-Y.;Wu, M.-S.;Kao, J.-H.;Mo, L.-R.;Tai, C.-M.;Lin, C.-W.;Yang, T.-H.;Lin, J.-T.;Hsu, Y.-C.; MING-SHIANG WU; JIA-HORNG KAO |
